SHEFFIELD (UK), May 2020 — Research from the University of Sheffield has given new insight into the cause of mutations in pluripotent stem cells and potential ways of stopping these mutations from occurring.
You are here
Coverage of the latest news and updates from the field of stem cells and regenerative medicine.
WASHINGTON DC (US), May 2020 — Trial results presented May 14 revealed a promising therapy for patients experiencing angina due to coronary microvascular dysfunction (CMD).
NEW YORK, NY (US), May 2020 — The first patients have been dosed in the 300-patient randomized placebo-controlled Phase 2/3 trial in the United States of Mesoblast Ltd.’s (Melbourne, Australia) allogeneic cellular medicine remestemcel-L in COVID
SAN DIEGO, CA (US), May 2020 — Global Institute of Stem Cell Therapy and Research (GIOSTAR) has received approval for a COVID-19 clinical trial, led by medical director Prabhat Soni, M.D.
ABU DHABI (AE), May 2020 — A patent has been granted by the United Arab Emirates Ministry of Economy for the development of a promising treatment for COVID-19 infections using stem cells.
HELSINKI (FI), May 2020 — Graft-versus-host disease (GvHD) is a potentially life-threatening medical condition that is common after allogeneic hematopoietic stem cell transplantation, the only curative treatment for various types of leukemias.
ZURICH (CH), May 2020 — Acute myeloid leukemia (AML) is an aggressive cancer of the blood-forming system. It affects the hematopoietic stem cells, or blood stem cells, of various white blood cells and of the red blood cells and platelets.
CORONA, CA, and MIAMI, FL, (US), April 2020 — RESTEM, a biotechnology company, and Baptist Health South Florida, announced that three COVID-19 patients with acute respiratory distress syndrome (ARDS) are the first to successfully be treated
PHILADELPHIA, PA (US), May 2020 — Like power lines in an electrical grid, long wiry projections that grow outward from neurons — structures known as axons — form interconnected communication networks that run from the brain to all parts of the b
TORONTO (CA), May 2020 — A group of researchers from University of Toronto Engineering and SickKids Hospital have developed a new way to deliver molecules that target specific genes within cells.